All In MedTech

Company

Telcare

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.

Private

Total raised (reported)

$34.7M

1 Form D offering, 2014 to 2014

Equity

$0

Stock sold for cash

Debt and convertible notes

$34.7M

$34.7M of it convertible

Last known valuation

Unknown

Form D filings do not report valuation

Latest round: convertible note, $34.7M raised of $36.7M sought, first sale Oct 3, 2014, 7 investors.

Funding rounds (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Oct 3, 2014Convertible note$34.7M$36.7M7Rule 506(b)Form D ↗Oct 20, 2014

Company details

From the company's latest Form D.

Legal name
Telcare, Inc.
Headquarters
Bethesda, Maryland
Incorporated
Delaware in 2009
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

    7 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    No 5%+ shareholder filings or SBIR grants found under the name Telcare.

    Latest FDA decisions

    Search the Clearance Tracker

    No 510(k), De Novo or PMA decisions under this name since 2015.

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar

    No device trials list this company as lead sponsor.

    Reports received

    2

    Received Nov 1, 2025 to Nov 20, 2026

    Malfunction reports

    2

    100% of reports

    Injury reports

    0

    0.0% of reports

    Death reports

    0

    0.0% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 230000
    Jan 241000
    Feb 243000
    Mar 241000
    Apr 241000
    May 240000
    Jun 240000
    Jul 240000
    Aug 242000
    Sep 240000
    Oct 240000
    Nov 240000
    Dec 242000
    Jan 252000
    Feb 251000
    Mar 250000
    Apr 250000
    May 250000
    Jun 250000
    Jul 250000
    Aug 250000
    Sep 252000
    Oct 253100
    Nov 250000
    Dec 250000
    Jan 261000
    Feb 261000
    Mar 260000
    Apr 260000
    May 260000
    Jun 260000
    Jul 260000
    Aug 260000
    Sep 260000
    Oct 260000
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    • Z-1270-2025 · Started Jan 30, 2025 · Posted by FDA Mar 5, 2025

      Reason given: Telcare, LLC has received customer complaints related to battery expansion/swelling for its Philips Connected Blood Glucose Meter (i.e., BGM 4 brand name) Monitoring System.. The issue was identified by post market surveillance data (customer complaints) - events of battery expansion/swelling and associated symptoms,...

      Cause as FDA categorized it: Software design · Device type: System, Test, Blood Glucose, Over The Counter (NBW)

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.